Filing Details
- Accession Number:
- 0001110803-12-000084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-12 18:46:55
- Reporting Period:
- 2012-04-11
- Filing Date:
- 2012-04-12
- Accepted Time:
- 2012-04-12 17:46:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263805 | O Christian Henry | 5200 Illumina Way San Diego CA 92122 | Sr Vp, General Manager Genomic | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-11 | 5,000 | $32.49 | 42,745 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-04-11 | 5,000 | $52.51 | 37,745 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-04-11 | 5,000 | $20.04 | 42,745 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-04-11 | 5,000 | $52.51 | 37,745 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-04-11 | 5,000 | $52.51 | 5,000 | $20.04 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-04-11 | 5,000 | $52.51 | 5,000 | $32.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 37,135 | 2007-02-25 | 2017-01-25 | No | 4 | M | Direct |
| 20,000 | 2008-02-29 | 2018-01-29 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sales price representing 5,000 shares sold ranging from $52.44 to $52.58 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
